arXiv Science⌕ Search

arXiv subjects

Alzheimer's Disease Neuroimaging Initiative

Publications and source records attributed to Alzheimer's Disease Neuroimaging Initiative.

14 recordsLinked to original sources

Decoupling Disease, Covariates, and Individual Variability: A Unified Disentanglement Framework for Medical Image Classification

Accurately isolating disease-related features from confounding covariates (e.g., age, gender, site) and individual variations remains a fundamental challenge in medical image classification. Traditional regression-based approaches may ignore non-linear relations between image features and true covariates. To overcome this issue, we present a generalized Medical Imaging Disentanglement Learning (MedIDL) framework. MedIDL maps image features into three mutually orthogonal latent spaces through specialized disentanglement heads: a disease classification head guided by a supervised loss, a covariate-alignment head constrained by cross-subject similarity matching, and a Gaussian head absorbing individual variations. We evaluated our framework across 7 datasets encompassing diverse imaging modalities. MedIDL outperforms state-of-the-art supervised and self-supervised classification methods in accuracy across all datasets. Association analyses demonstrate that MedIDL successfully isolates target-specific latent representations. Gradient-based interpretability mappings localize pathognomonic patterns aligning with established clinical literature.

cs.CV↗

Large-Scale Deployment and Analytical Implications of Structured Quality Control in Diffusion Magnetic Resonance Imaging

Purpose: Diffusion MRI (dMRI) provides a diverse set of quantitative measures and derived datatypes to assess white matter microstructure and macrostructure. Coupled with the increasing size of imaging studies using dMRI, the number of downstream outputs requiring quality control (QC) will continue to grow. Previous work has shown that failure modes which are often not evident from aggregate metrics or summary statistics can be identified through structured visual inspection. This work aims to better understand common failure modes and the expected characteristics of valid dMRI processing outputs to ensure the validity and interpretability of quantitative findings. Approach: We deployed a structured QC framework to assess 18,328 dMRI scans across nine datasets, visually evaluating the outputs of seven processing pipelines representative of conventional dMRI analyses. Results: Downstream outputs that pass visual QC may still rely on failed upstream dependencies; such failures may only be visually detectable through systematic inspection of the full pipeline hierarchy. Additionally, appropriate QC granularity is algorithm-specific, as the spatial structure of each algorithm's outputs determines whether failures warrant selective or global exclusion. Conclusion: This work demonstrates the feasibility and analytical value of large-scale, structured QC for dMRI processing pipelines. Our results highlight the need for systematic QC spanning the full processing hierarchy to ensure the validity and interpretability of quantitative findings.

eess.IV↗

Robust-ComBat: Mitigating Outlier Effects in Diffusion MRI Data Harmonization

Harmonization methods such as ComBat and its variants are widely used to mitigate diffusion MRI (dMRI) site-specific biases. However, ComBat assumes that subject distributions exhibit a Gaussian profile. In practice, patients with neurological disorders often present diffusion metrics that deviate markedly from those of healthy controls, introducing pathological outliers that distort site-effect estimation. This problem is particularly challenging in clinical practice as most patients undergoing brain imaging have an underlying and yet undiagnosed condition, making it difficult to exclude them from harmonization cohorts, as their scans were precisely prescribed to establish a diagnosis. In this paper, we show that harmonizing data to a normative reference population with ComBat while including pathological cases induces significant distortions. Across 7 neurological conditions, we evaluated 10 outlier rejection methods with 4 ComBat variants over a wide range of scenarios, revealing that many filtering strategies fail in the presence of pathology. In contrast, a simple MLP provides robust outlier compensation enabling reliable harmonization while preserving disease-related signal. Experiments on both control and real multi-site cohorts, comprising up to 80% of subjects with neurological disorders, demonstrate that Robust-ComBat consistently outperforms conventional statistical baselines with lower harmonization error across all ComBat variants.

cs.CV↗

Adaptive Clinical-Aware Latent Diffusion for Multimodal Brain Image Generation and Missing Modality Imputation

Multimodal neuroimaging provides complementary insights for Alzheimer's disease diagnosis, yet clinical datasets frequently suffer from missing modalities. We propose ACADiff, a framework that synthesizes missing brain imaging modalities through adaptive clinical-aware diffusion. ACADiff learns mappings between incomplete multimodal observations and target modalities by progressively denoising latent representations while attending to available imaging data and clinical metadata. The framework employs adaptive fusion that dynamically reconfigures based on input availability, coupled with semantic clinical guidance via GPT-4o-encoded prompts. Three specialized generators enable bidirectional synthesis among sMRI, FDG-PET, and AV45-PET. Evaluated on ADNI subjects, ACADiff achieves superior generation quality and maintains robust diagnostic performance even under extreme 80\% missing scenarios, outperforming all existing baselines. To promote reproducibility, code is available at https://github.com/rongzhou7/ACADiff

cs.CV↗

Spatio-Temporal Graph Deep Learning with Stochastic Differential Equations for Uncovering Alzheimer's Disease Progression

Identifying objective neuroimaging biomarkers to forecast Alzheimer's disease (AD) progression is crucial for timely intervention. However, this task remains challenging due to the complex dysfunctions in the spatio-temporal characteristics of underlying brain networks, which are often overlooked by existing methods. To address these limitations, we develop an interpretable spatio-temporal graph neural network framework to predict future AD progression, leveraging dual Stochastic Differential Equations (SDEs) to model the irregularly-sampled longitudinal functional magnetic resonance imaging (fMRI) data. We validate our approach on two independent cohorts, including the Open Access Series of Imaging Studies (OASIS-3) and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Our framework effectively learns sparse regional and connective importance probabilities, enabling the identification of key brain circuit abnormalities associated with disease progression. Notably, we detect the parahippocampal cortex, prefrontal cortex, and parietal lobule as salient regions, with significant disruptions in the ventral attention, dorsal attention, and default mode networks. These abnormalities correlate strongly with longitudinal AD-related clinical symptoms. Moreover, our interpretability strategy reveals both established and novel neural systems-level and sex-specific biomarkers, offering new insights into the neurobiological mechanisms underlying AD progression. Our findings highlight the potential of spatio-temporal graph-based learning for early, individualized prediction of AD progression, even in the context of irregularly-sampled longitudinal imaging data.

cs.LG↗

An Optimized PatchMatch for Multi-scale and Multi-feature Label Fusion

Automatic segmentation methods are important tools for quantitative analysis of Magnetic Resonance Images (MRI). Recently, patch-based label fusion approaches have demonstrated state-of-the-art segmentation accuracy. In this paper, we introduce a new patch-based label fusion framework to perform segmentation of anatomical structures. The proposed approach uses an Optimized PAtchMatch Label fusion (OPAL) strategy that drastically reduces the computation time required for the search of similar patches. The reduced computation time of OPAL opens the way for new strategies and facilitates processing on large databases. In this paper, we investigate new perspectives offered by OPAL, by introducing a new multi-scale and multi-feature framework. During our validation on hippocampus segmentation we use two datasets: young adults in the ICBM cohort and elderly adults in the EADC-ADNI dataset. For both, OPAL is compared to state-of-the-art methods. Results show that OPAL obtained the highest median Dice coefficient (89.9% for ICBM and 90.1% for EADC-ADNI). Moreover, in both cases, OPAL produced a segmentation accuracy similar to inter-expert variability. On the EADC-ADNI dataset, we compare the hippocampal volumes obtained by manual and automatic segmentation. The volumes appear to be highly correlated that enables to perform more accurate separation of pathological populations.

cs.CV↗

IGCN: Integrative Graph Convolution Networks for patient level insights and biomarker discovery in multi-omics integration

Developing computational tools for integrative analysis across multiple types of omics data has been of immense importance in cancer molecular biology and precision medicine research. While recent advancements have yielded integrative prediction solutions for multi-omics data, these methods lack a comprehensive and cohesive understanding of the rationale behind their specific predictions. To shed light on personalized medicine and unravel previously unknown characteristics within integrative analysis of multi-omics data, we introduce a novel integrative neural network approach for cancer molecular subtype and biomedical classification applications, named Integrative Graph Convolutional Networks (IGCN). IGCN can identify which types of omics receive more emphasis for each patient to predict a certain class. Additionally, IGCN has the capability to pinpoint significant biomarkers from a range of omics data types. To demonstrate the superiority of IGCN, we compare its performance with other state-of-the-art approaches across different cancer subtype and biomedical classification tasks.

cs.LG↗

Enhancing Longitudinal Clinical Trial Efficiency with Digital Twins and Prognostic Covariate-Adjusted Mixed Models for Repeated Measures (PROCOVA-MMRM)

Clinical trials are critical in advancing medical treatments but often suffer from immense time and financial burden. Advances in statistical methodologies and artificial intelligence (AI) present opportunities to address these inefficiencies. Here we introduce Prognostic Covariate-Adjusted Mixed Models for Repeated Measures (PROCOVA-MMRM) as an advantageous combination of prognostic covariate adjustment (PROCOVA) and Mixed Models for Repeated Measures (MMRM). PROCOVA-MMRM utilizes time-matched prognostic scores generated from AI models to enhance the precision of treatment effect estimators for longitudinal continuous outcomes, enabling reductions in sample size and enrollment times. We first provide a description of the background and implementation of PROCOVA-MMRM, followed by two case study reanalyses where we compare the performance of PROCOVA-MMRM versus the unadjusted MMRM. These reanalyses demonstrate significant improvements in statistical power and precision in clinical indications with unmet medical need, specifically Alzheimer's Disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We also explore the potential for sample size reduction with the prospective implementation of PROCOVA-MMRM, finding that the same or better results could have been achieved with fewer participants in these historical trials if the enhanced precision provided by PROCOVA-MMRM had been prospectively leveraged. We also confirm the robustness of the statistical properties of PROCOVA-MMRM in a variety of realistic simulation scenarios. Altogether, PROCOVA-MMRM represents a rigorous method of incorporating advances in the prediction of time-matched prognostic scores generated by AI into longitudinal analysis, potentially reducing both the cost and time required to bring new treatments to patients while adhering to regulatory standards.

stat.AP↗

Thalamic nuclei segmentation from T$_1$-weighted MRI: unifying and benchmarking state-of-the-art methods with young and old cohorts

The thalamus and its constituent nuclei are critical for a broad range of cognitive and sensorimotor processes, and implicated in many neurological and neurodegenerative conditions. However, the functional involvement and specificity of thalamic nuclei in human neuroimaging is underappreciated and not well studied due, in part, to technical challenges of accurately identifying and segmenting nuclei. This challenge is further exacerbated by a lack of common nomenclature for comparing segmentation methods. Here, we use data from healthy young (Human Connectome Project, 100 subjects) and older healthy adults, plus those with minor cognitive impairment and Alzheimer$'$s disease (Alzheimer$'$s Disease Neuroimaging Initiative, 540 subjects), to benchmark four state of the art thalamic segmentation methods for T1 MRI (FreeSurfer, HIPS-THOMAS, SCS-CNN, and T1-THOMAS) under a single segmentation framework. Segmentations were compared using overlap and dissimilarity metrics to the Morel stereotaxic atlas. We also quantified each method$'$s estimation of thalamic nuclear degeneration across Alzheimer$'$s disease progression, and how accurately early and late mild cognitive impairment, and Alzheimers disease could be distinguished from healthy controls. We show that HIPS-THOMAS produced the most effective segmentations of individual thalamic nuclei and was also most accurate in discriminating healthy controls from those with mild cognitive impairment and Alzheimer$'$s disease using individual nucleus volumes. This work is the first to systematically compare the efficacy of anatomical thalamic segmentation approaches under a unified nomenclature. We also provide recommendations of which segmentation method to use for studying the functional relevance of specific thalamic nuclei, based on their overlap and dissimilarity with the Morel atlas.

eess.IV↗

A Multi-task Deep Feature Selection Method for Brain Imaging Genetics

Using brain imaging quantitative traits (QTs) to identify the genetic risk factors is an important research topic in imaging genetics. Many efforts have been made via building linear models, e.g. linear regression (LR), to extract the association between imaging QTs and genetic factors such as single nucleotide polymorphisms (SNPs). However, to the best of our knowledge, these linear models could not fully uncover the complicated relationship due to the loci's elusive and diverse impacts on imaging QTs. Though deep learning models can extract the nonlinear relationship, they could not select relevant genetic factors. In this paper, we proposed a novel multi-task deep feature selection (MTDFS) method for brain imaging genetics. MTDFS first adds a multi-task one-to-one layer and imposes a hybrid sparsity-inducing penalty to select relevant SNPs making significant contributions to abnormal imaging QTs. It then builds a multi-task deep neural network to model the complicated associations between imaging QTs and SNPs. MTDFS can not only extract the nonlinear relationship but also arms the deep neural network with the feature selection capability. We compared MTDFS to both LR and single-task DFS (DFS) methods on the real neuroimaging genetic data. The experimental results showed that MTDFS performed better than both LR and DFS in terms of the QT-SNP relationship identification and feature selection. In a word, MTDFS is powerful for identifying risk loci and could be a great supplement to the method library for brain imaging genetics.

q-bio.GN↗

Revisiting convolutional neural network on graphs with polynomial approximations of Laplace-Beltrami spectral filtering

This paper revisits spectral graph convolutional neural networks (graph-CNNs) given in Defferrard (2016) and develops the Laplace-Beltrami CNN (LB-CNN) by replacing the graph Laplacian with the LB operator. We then define spectral filters via the LB operator on a graph. We explore the feasibility of Chebyshev, Laguerre, and Hermite polynomials to approximate LB-based spectral filters and define an update of the LB operator for pooling in the LBCNN. We employ the brain image data from Alzheimer's Disease Neuroimaging Initiative (ADNI) and demonstrate the use of the proposed LB-CNN. Based on the cortical thickness of the ADNI dataset, we showed that the LB-CNN didn't improve classification accuracy compared to the spectral graph-CNN. The three polynomials had a similar computational cost and showed comparable classification accuracy in the LB-CNN or spectral graph-CNN. Our findings suggest that even though the shapes of the three polynomials are different, deep learning architecture allows us to learn spectral filters such that the classification performance is not dependent on the type of the polynomials or the operators (graph Laplacian and LB operator).

cs.LG↗

Fast Mesh Data Augmentation via Chebyshev Polynomial of Spectral filtering

Deep neural networks have recently been recognized as one of the powerful learning techniques in computer vision and medical image analysis. Trained deep neural networks need to be generalizable to new data that was not seen before. In practice, there is often insufficient training data available and augmentation is used to expand the dataset. Even though graph convolutional neural network (graph-CNN) has been widely used in deep learning, there is a lack of augmentation methods to generate data on graphs or surfaces. This study proposes two unbiased augmentation methods, Laplace-Beltrami eigenfunction Data Augmentation (LB-eigDA) and Chebyshev polynomial Data Augmentation (C-pDA), to generate new data on surfaces, whose mean is the same as that of real data. LB-eigDA augments data via the resampling of the LB coefficients. In parallel with LB-eigDA, we introduce a fast augmentation approach, C-pDA, that employs a polynomial approximation of LB spectral filters on surfaces. We design LB spectral bandpass filters by Chebyshev polynomial approximation and resample signals filtered via these filters to generate new data on surfaces. We first validate LB-eigDA and C-pDA via simulated data and demonstrate their use for improving classification accuracy. We then employ the brain images of Alzheimer's Disease Neuroimaging Initiative (ADNI) and extract cortical thickness that is represented on the cortical surface to illustrate the use of the two augmentation methods. We demonstrate that augmented cortical thickness has a similar pattern to real data. Second, we show that C-pDA is much faster than LB-eigDA. Last, we show that C-pDA can improve the AD classification accuracy of graph-CNN.

cs.LG↗

GANBERT: Generative Adversarial Networks with Bidirectional Encoder Representations from Transformers for MRI to PET synthesis

Synthesizing medical images, such as PET, is a challenging task due to the fact that the intensity range is much wider and denser than those in photographs and digital renderings and are often heavily biased toward zero. Above all, intensity values in PET have absolute significance, and are used to compute parameters that are reproducible across the population. Yet, usually much manual adjustment has to be made in pre-/post- processing when synthesizing PET images, because its intensity ranges can vary a lot, e.g., between -100 to 1000 in floating point values. To overcome these challenges, we adopt the Bidirectional Encoder Representations from Transformers (BERT) algorithm that has had great success in natural language processing (NLP), where wide-range floating point intensity values are represented as integers ranging between 0 to 10000 that resemble a dictionary of natural language vocabularies. BERT is then trained to predict a proportion of masked values images, where its "next sentence prediction (NSP)" acts as GAN discriminator. Our proposed approach, is able to generate PET images from MRI images in wide intensity range, with no manual adjustments in pre-/post- processing. It is a method that can scale and ready to deploy.

eess.IV↗

GANDALF: Generative Adversarial Networks with Discriminator-Adaptive Loss Fine-tuning for Alzheimer's Disease Diagnosis from MRI

Positron Emission Tomography (PET) is now regarded as the gold standard for the diagnosis of Alzheimer's Disease (AD). However, PET imaging can be prohibitive in terms of cost and planning, and is also among the imaging techniques with the highest dosage of radiation. Magnetic Resonance Imaging (MRI), in contrast, is more widely available and provides more flexibility when setting the desired image resolution. Unfortunately, the diagnosis of AD using MRI is difficult due to the very subtle physiological differences between healthy and AD subjects visible on MRI. As a result, many attempts have been made to synthesize PET images from MR images using generative adversarial networks (GANs) in the interest of enabling the diagnosis of AD from MR. Existing work on PET synthesis from MRI has largely focused on Conditional GANs, where MR images are used to generate PET images and subsequently used for AD diagnosis. There is no end-to-end training goal. This paper proposes an alternative approach to the aforementioned, where AD diagnosis is incorporated in the GAN training objective to achieve the best AD classification performance. Different GAN lossesare fine-tuned based on the discriminator performance, and the overall training is stabilized. The proposed network architecture and training regime show state-of-the-art performance for three- and four- class AD classification tasks.

eess.IV↗